CODRIX (ACETAMINOPHEN; CODEINE PHOSPHATE) — FDA Approval ANDA040447 (WATSON LABS FLORIDA)
CODRIX (ACETAMINOPHEN; CODEINE PHOSPHATE) — FDA Approval ANDA040447 (WATSON LABS FLORIDA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CODRIX; Active ingredients: ACETAMINOPHEN; CODEINE PHOSPHATE; Application number: ANDA040447.
| Brand name | CODRIX |
|---|---|
| Active ingredients | ACETAMINOPHEN; CODEINE PHOSPHATE |
| Application number | ANDA040447 |
| Sponsor | WATSON LABS FLORIDA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20030226 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →